Overview

Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis

Status:
Withdrawn
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The study purpose is to characterize the effect of pancreatic enzyme supplementation on chronic pancreatitis type pain.
Phase:
Phase 2
Details
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Treatments:
Pancreatin
Pancrelipase